Gut Microbiome Associates With Lipid-Lowering Effect of Rosuvastatin in Vivo

Frontiers in Microbiology - Switzerland
doi 10.3389/fmicb.2018.00530
Full Text
Abstract

Available in full text

Categories
Microbiology
Date
Authors
Publisher

Frontiers Media SA

Related search

Lipid Lowering Efficacy and Safety of Ezetimibe Combined With Rosuvastatin Compared With Titrating Rosuvastatin Monotherapy in HIV-positive Patients

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2015English

Effect of Intensive Lipid-Lowering Therapy With Rosuvastatin on Progression of Carotid Intima-Media Thickness in Japanese Patients

Circulation Journal
MedicineCardiovascular MedicineCardiology
2012English

Effects of Lipid-Lowering Therapy With Rosuvastatin on Atherosclerotic Burden in Patients With Chronic Kidney Disease

Internal Medicine
Internal MedicineMedicine
2008English

Psoriasis, Gut and Microbiome

British Journal of Dermatology
DermatologyMedicine
2019English

Effect of Lipid-Lowering Treatment in Cardiovascular Disease Prevalence in Familial Hypercholesterolemia

Atherosclerosis
Cardiovascular MedicineCardiology
2019English

Alterations of the Gut Microbiome in Hypertension

Frontiers in Cellular and Infection Microbiology
MedicineInfectious DiseasesImmunologyMicrobiology
2017English

The Human Gut Microbiome

JAMA Surgery
Surgery
2013English

Adherence to Lipid Lowering Drugs in Patients With Schizophrenia

Clinical Therapeutics
Pharmacology
2017English

Gut Microbiome in Chronic Kidney Disease

Sohag Medical Journal
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy